Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients

This study has been completed.
University of Arizona
Universidad Nacional Autonoma de Mexico
Information provided by:
Instituto Bioclon S.A. de C.V. Identifier:
First received: May 23, 2008
Last updated: June 1, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2005
  Primary Completion Date: August 2005 (Final data collection date for primary outcome measure)
No publications provided by Instituto Bioclon S.A. de C.V.

Publications automatically indexed to this study by Identifier (NCT Number):